Recruiting

Virtual Physical Activity

Sponsor:

University of British Columbia

Code:

NCT05724823

Conditions

Stroke

Chronic Stroke

Stroke, Ischemic

Stroke Hemorrhagic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Virtual Physical Activity Seated Exercises (V-PASE)

Study Details

Brief summary:

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.

Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Conditions

Stroke

Chronic Stroke

Stroke, Ischemic

Stroke Hemorrhagic

Study ID

NCT05724823

Start date

Oct 11, 2023

Status verified date

Mar, 2025

Completion date

Dec, 2026

Anticipated

Primary completion date

Dec, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Participants must meet the following inclusion criteria:

  • Adult (as defined by Province)
  • Chronic stroke (more than 6 months post-stroke)
  • Ability to stand up from a chair
  • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
  • Able to safely engage in exercise and tolerate 60 minutes of exercises
  • Able to communicate in English
  • Have access to a tablet, computer, or laptop with internet and email access

Exclusion Criteria:

Participants will be excluded if they meet any of the following criteria:

  • Participating in formal exercise or rehabilitation activities
  • Participating in > 30 minutes/day of physical activity (moderate intensity)
  • Participating in another study that may affect outcomes to this study
  • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
  • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
  • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)

Study Design

Enrollment

100 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: 10-week group

Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration.

no intervention: Delayed 2-week group (Boot Camp)

The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period.

Interventions

Virtual Physical Activity Seated Exercises (V-PASE)

The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

Primary outcome measure

  • 30 Second Sit-to-Stand [ Time Frame: Immediately post-intervention (following 10-week trial) ]

Central Contacts and Locations

Central contacts

Locations

GF Strong Rehabilitation Centre

Recruiting

Vancouver, British Columbia, Canada, V5Z 2G9

Contacts

University of Manitoba

Recruiting

Winnipeg, Manitoba, Canada

Nova Scotia Health

Recruiting

Halifax, Nova Scotia, Canada

Western University

Recruiting

London, Ontario, Canada

University of Saskatchewan

Recruiting

Saskatoon, Saskatchewan, Canada

More Information

Sponsor

University of British Columbia

Last update posted

Mar 10, 2025

Last verified

Mar, 2025

Keywords

  • Stroke
  • Seated Exercise
  • Balance
  • Mobility
  • Cardiometabolic health
  • Randomized Controlled Trial

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of British Columbia on 2025-03-10.